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Dilatation Patent Mild Re-do Grafts Medical Aggra- With- Cumulative
(stenosis) (G-50%) (55-70%1 (75%-) 175%-) 175%-) vated# drawal G-70% No.'"
1st 874 67 384 9 16 32 73 941 1382
2nd 221 22 97 a 6 7 31 1184 1351
3rd 53 11 23 a 1 3 6 1248 1345
4th 11 1 8 1 a 1 a 1261 1345
5th 3 3 2 a a a a 1267 1345
6th 1 a a 1 a a a 1268 1345
*:1763- 1: Withdrawal. # :sudden death. acute infarction or irreversible occlusion
Conclusion: These findings indicate that 1) repeat angioplasty can be the
main treatment strategy for restenosis, 2) multiple repeat angioplasties (up
to 6 times) can be effective and rarely aggravate coronary anatomy and 31
disease aggravation must be prevented to improve the final patency rate of
repeat ang ioplasty.
Linear ultrasound contrast echo data was digitally stored on optical disc and
quantified using a specially developed software package. Measured param-
eters were peak contrast effect (P), area under the contrast echo curve (A).
time to peak contrast effect, contrast half-time and mean transit time. Con-
trast effect in the myocardial bed of the index artery Ii) was also compared
with that in a reference bed supplied by a normal artery (r). Nine patients
("viable group") had an improvement in echo score at 1 month while 5 pa-
tients ("non-viable" group) had no improvement. The "viable" patients had an
improvement in ejection fraction (52.1 % to 55.5%, P < 0.02) as well as wall
motion index score (1.4 to 1.1, p < 0.04) while the "non-viable" patients had
no significant improvement in either parameter (49.0% to 42.8% and 1.5 to
1.61. Significant contrast data was:
Pli) Pli)!P(rl Ali) A(iI/A(r)
'Vlable" 184 0.54 66.1 0.51
"Non-viable" 064 0.22 20.0 0.22
P value p < 0.04 P < 0.01 P < 0.02 P < 0.05
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P and A were significantly greater in the index myocardial bed in the "vi-
able" group compared to the "non-viable" group. Despite a patent epicardial
index coronary artery, 4/5 patients in the "non-viable" group demonstrated
minimal contrast effect in the index myocardial segment. These initial results
suggest that ICE prior to PTCA may be rapidly used to predict improvement in
both regional and global left ventricular function. The contrast data is additive
to that obtained by angiography and identification of a contrast "watershed"
value should enable a valuable echo predictor of myocardial viability.
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1752-31 Evaluation of Regional Myocardial Perfusion in Early
Pacing-induced Left Ventricular Dysfunction Using
Myocardial Contrast Echocardiography
Shiro Nozaki, Anthony N. DeMaria. Valmik Bhargava. Bruno Cotter, H.
Kirk Hammond. UCSD and VAMC-San Diego, CA
Sustained rapid left ventricular ILV) pacing has been used to induce conges-
tive heart failure, but whether regional myocardial perfusion contributes to
the development of myocardial dysfunction is unknown. Therefore, we ex-
amined 4 pigs before and sequentially during sustained rapid LV pacing (225
bpm) from the at posterolateral epicardium. We performed myocardial con-
trast echocardiography (MCE) with left atrial injection of an investigational
galactose contrast agent prior to pacing and daily for 4 days after onset of
pacing. Pacemakers were inactivated for 60 min prior to data acquisition.
The ratio of peak intensity after injection and baseline intensity of region of
interest (peak intensity ratio) was measured at 8 segments (Fig) in the short
axis view at the tip of papillary muscle using video intensitometry. Percent
wall thickening I%WTh) in the interventricular septum (IVS) and posterolat-
eral wall (PLW) were assessed by M-mode echo. Over the 4 days of pacing,
the peak intensity ratio progressively decreased in the PLW [region 4 (p <
0.01). 5 (p < 0.001),6 (p < 0.051] but did not decrease in other regions. Sig-
nificant regional-specific changes were observed between region 4 vs 8 (p <
0.0002). and region 5 vs 8 (p < 0.0001). Similarly, %WTh in the PLW progres-
sively decreased (p < 0.0001) but was unchanged in the IVS. Conclusion:
These data suggest that sustained rapid LV pacing produces regional my-
ocardial dysfunction in the initial development of LV failure. Myocardial con-
trast echocardiography suggests that relative hypoperfusion may contribute
to regional myocardial dysfunction in this model.
1752-41 Transient Intracoronary Infusion of ATP After
Reperfuslon Reduces the Extent of No-reflow and
Infarct Size in Dogs
Kazuo Komamura. Hiroshi Ito 1, Shin Takiuchi 1, Katsuomi Iwakura 1,
Atsushi Maruyama 1, Tohru Masuyama, Tetsuo Minamino. Koichi Node,
Masafumi Kitakaze. Masatsugu Hori. The 1st Dept ofMed.. Osaka Univ, School of
Med., Osaka, Japan; 1 Sakurabashi Watanabe Hospital. Osaka, Japan
It is now widely acknowledged that preconditioning (PC) before severe is-
chemic insults reduces infarct size (IS) and may attenuate the extent of no-
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Microcirculatory Flow Dynamics During Peripheral
Intravenous Injection of Echogen'": Microscopic
Visualization of Mesenteric Microcirculatory Flow
with Simultaneous Transthoracic Echo Imaging in
Cats
Shuping Ge. George G. Giraud. Takahiro Shiota, George A. Pantely, Jinping Xu,
Zheng Gong. Masahiro Ishii, Xiaodong Zhou. Arthur Hall, David J. Sahn. Oregon
Hlth Sci Univ, Portland. OR
Echogen '" , a phase shift. fluorocarbon gas echo contrast agent, has been
shown capable of producing left ventricular and robust myocardial opaci-
fication, persisting up to 35 to 40 mm after peripheral venous injection.
We investigated the microcirculatory flow dynamics of this agent in the cat
mesenteric vascular bed using microscopic visualization of capillary flows.
Four cats (weight 2 to 5.2 kg, mean = 3.2 kg) were anesthetized and ven-
tilated. Systemic arterial blood pressure was monitored by cannulation of
the carotid artery. Microscopic examination (x 400) with an instrument cali-
brated for scale was performed by placing a loop of small intestine on awarm
water bath stage and transilluminating the mesentery with a xenon light
source while videotape recording the images for off-line analysis. Transtho-
racic echocardiography was performed simultaneously using a TOSHIBA
140A system with a 7 MHz transducer. Doses of 0.4, 06, 0.8 mllkg la total of
15 injections) of Echogen were administered intravenously. For all the injec-
tions, Visually apparent left ventricular and intense myocardial opacification
was achieved lasting up to 20 minutes. A transient drop in arterial blood pres-
sure (25 ± 13.2 mmHg) was observed with the high dose 10.8 ml/kg). which
returned to baseline within 5 mins. Capillary flow velocities of the red blood
cells before and after Echogen injection were 4.3 ± 1.7 mmlsec dropping to
2.3 ± 0.9 mm/sec, the drop occurred 5 to 20 seconds following injections
and recovery was within 40-70 seconds. Transient slowing and periodicity
of flow was noted in the venule side of the capillaries. but arteriolar capil-
lary flow changed little during brisk transit of the observed bubbles. There
was no significant difference in flow velocity changes associated with differ-
ent doses (p > 0.05). Also, margination and endothelial adhesion of bubbles
observed in larger arteriolar feeding vessels without slowing of central RBC
flow suggests a mechanism for the long persistence of echo contrast bub-
bles in the tissue without vascular blockage or evidence of myocardial tissue
damage.
Clinical Applications of Myocardial Contrast
Echocardiography
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1752-21 Intra-coronary Contrast Echocardiography Predicts
Myocardial Viability Prior to PTCA
Martyn Thomas, Ray Wainwright. Stephen Holmberg. Richard Wray, David Jewitt.
Mark Monaghan. King's College Hospital, London, UK
A rapid method for predicting myocardial viability prior to revascularisation
remains elusive. Intra-coronary contrast echocardiography (ICE) evaluates
myocardial perfusion and may have a role in predicting myocardial viability by
demonstrating flow at a microvascular level. ICE was performed before PTCA
in 14 patients who had a wall motion abnormality associated with the index
artery (LAD = 11 RCA = 3). There were 10 men and 4 women with a mean
age of 63 years (range 54-74 years). Echo derived wall motion score and
global ejection fraction were calculated before PTCA and again at 1 month.
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reflow. However, in the clinical settings, interventional modalities prior to
reperfusion cannot be available. A putative mediator of PC, adenosine can
be obtained as a metabolite of ATP which is readily available for clinical use.
Thus we attempted to test whether the administration of ATP directly into
the reperfused area reduces the extent of no-reflow and infarct size. ATP
(4 mglkg/minl was administered for 10 min after reperfusion following 2hrs
occlusion of the left anterior descending artery (LAD) via the retrograde can-
nulation to the left main trunk through the segment distal to the first diago-
nal branch of LAD in the anesthetized open-chest dogs. Myocardial contrast
echocardiography (MCE) with Albunex at 2hrs of reperfusion revealed the
ratio of no-reflow area to risk area was smaller in ATP group than that in the
control group (0.14 ± 0.08 vs. 0.51 ± 0.12, mean ± SE, n = 5 each, p < 0.051.
nC-staining after 3hrs reperfusion revealed the reduction of IS normalized
by risk area in ATP group than that in the control group (13.9 ± 2.4% vs. 34.0
± 17.6%, P < 0.05). Furthermore, there was no advanced bradycardia during
the infusion of ATP. Thus we conclude that transient intracoronary infusion
of ATP into the reperfused area reduces the extent of no-reflow and IS. In-
tracoronary ATP administration can be a beneficial adjunctive therapy after
reperfusion in acute myocardial infarction.
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1752-51 Dose the "No Reflow" Phenomenon Immediately
After Successful Direct Angloplasty Always Indicate
Poor Functional Recovery?
Hirofumi Kajiyama, Hironori Hirai, Makolo Suzuki, Tetsuo Lee, Yuko Sugiyama,
Alsushi Tokuyama, Masahiko Harada, Toshiyuki Degawa, Shigeki Nishizawa,
So Yabuki, Tetsu Yamaguchi. Toho University Ohashi Hospital, Tokyo, Japan
Experimental studies have demonstrated that "no reflow" phenomenon af-
ter prolonged coronary occlusion indicates advanced myocardial necrosis.
In clinical settings, previous studies have suggested that presence of "no
reflow" phenomenon following thrombolysis is a useful predictor of poor
functional recovery. To test the hypothesis that "no reflow" phenomenon is
closely related to the recovery of regional wall motion in a reperfused AMI,
we studied 42 myocardial segments in 18 patients with AMI who achieved
successful direct angioplasty. MCE was performed immediately after direct
angioplasty and repeated 2 weeks later with intracoronary injection of soni-
cated albumin. Contrast effect in each segment was scored as 0-2 (0, 1 and
2 denoting no, partial and homogeneous contrast effect, respectively). 20-
Echo was performed at day-1 and repeated 1 month later. Wall motion (WMI
by 2D-Echo was scored as 0-3 (scores of 0 to 3 indicating dys/akinetic seg-
ments to normal. respectively). The relation between mean WM and MCE
score immediately after direct angioplasty was as follows:
MCE score day-l WM 1 MonlhWM Change
2 (n = 20) 1.1 ± 0.8** 1.7 ± 0.7*# 0.6 ± 09
1 (n = 7) 0.6 ± O.S* 1.4± 1.4# 0.9 ± 0.9
O(n = 15) 00 ± 0.0 O.S ± 1.0## O.S ± 1.0
*p < 0.01," p < 0.001 vs. MCE score = 0, #p < 0.05, ##p < 0.01 vs. day-l WM
Seven of 15 segments (47%) with MCE score = 0 immediately after di-
rect angioplasty showed functional recovery at 1 month later, and 6 of the 7
segments (86%) showed contrast enhancement at 2 weeks later restudy.
Conclusion: About one half of segments which showed no contrast en-
hancement immediately after direct angioplasty showed functional recovery
at 1 month later, and the majority of these segments showed contrast en-
hancement at 2 weeks later restudy. The "no reflow" phenomenon by MCE
immediately after successful direct angioplasty dose not always indicate
poor functional recovery.
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Visualization of Coronary Arteries and Measurement
of Coronary Blood Flow with Transthoracic
Echocardiography After Intravenous Administration
of a New Echocardlographic Contrast Agent
Sharon L. Mulvagh, David A. Foley, Kyle K. Klarich, Beat C. Aeschbacher,
Chuwa Tei, James B. Seward. Mayo Clinic, Rochester MN
Imagent® US (AF0145, Alliance Pharmaceutical Corp.), a new hemodynam-
ically inert perfluorochemical echocardiographic contrast agent, produces
excellent left ventricular and blood pool contrast effect after intravenous ad-
ministration when imaged with conventional (2-D) ultrasound. We evaluated
the potential of Contrast Specific Imaging (Acuson) employing second har-
monic principles to further enhance the visualization of structures contain-
ing contrast agents. Transthoracic images were obtained during injections of
10-40 mg of the agent into the left femoral vein of seven closed chest dogs.
Coronary Dopplerflow was simultaneously measured using an intracoronary
Doppler wire. No alterations in flow velocities were observed with contrast
administration. There was heterogenous opacification of the myocardium
following contrast injection: a striking finding was of contrast-enhanced lin-
ear, branching structures in the myocardium consistent with coronary ves-
sels. Further exploration of the largest structures (2-3 mm diameter) in the
region of the basal ventricular septum was technically possible with pulsed
wave Doppler in two dogs. A characteristic coronary Doppler flow pattern
was observed (Fig 1a). Transthoracic Doppler flow velocities transiently in-
creased after intracoronary adenosine (Fig 1b). The calculated coronary flow
reserve ratio was similar to simultaneous intracoronary Doppler measure-
ments. Conclusions: Intramyocardial coronaryvasculature was observed and
coronary flow velocites were measured during transthoracic Contrast Spe-
cific Imaging with an intravenously administered contrast agent. These find-
ings suggest that noninvasive assessment of coronary blood flow is possible
with echocardiographic contrast enhancement.
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1753-1 I The Diagnostic and Management Role of
Transesophageal Echocardiography in the Evaluation
of the Thoracic Aorta - the Expanding View
Andrew J. Gresko, Alan Appelbe, Thomas Martin, Randolph P. Martin. Emory
University; Atlanta, Ga
The purpose of this study was to examine the accuracy, determine the spec-
trum of aortic disease and the effect that transesophageal echocardiography
has on the clinical management in a consecutive series of patients referred
for assessment of aortic disease.
A retrospective review of 75 patients undergoing TEE for aortic pathol-
ogy was performed. A wide spectrum of disease was encountered: atypical
aortic dissections (16). typical aortic dissections (22), aortic aneurysms (13).
atheromatous aortas (14), aortic transection (3). Takayasu's arteritis, aortic
contusion, coarctation and a penetrating ulcer. The sensitivity and specificity
was 96% and 98% respectively. In patients with aortic dissections, 42% of
aortic dissections were atypical due to: without an intimal falp (5). unusual 10-
calization (4). pre-existing surgery (3), unusual flap morphology (2), and aortic
complications (2). TEE altered the diagnosis made by computed tomography
in 26% and was the only test in 37%. Of these, 35% had immediate surgery
without further investigations. The TEE affected the management of 63% of
the patients with aortic dissections.
Conclusions: Transesophageal echocardiography is accurate across a
broad spectrum of aortic disease, not just aortic dissection. Atypical aortic
dissections are frequently encountered. Transesophageal echocardiography
altered or changed management in 63% of patients with aortic dissection.
